Shares of IVERIC bio Inc. (ISEE), formerly Ophthotech Corp., have climbed more than 690% in just two months, thanks to the encouraging Zimura clinical trial results in geographic atrophy secondary to dry age-related macular degeneration.
from RTT - Biotech https://ift.tt/2sb9oc8
via IFTTT
No comments:
Post a Comment